CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function

Journal of Virology

Volumn 73, Issue 3, 1999, Pages 2450-2459

  Mariani, Roberto ^a   Wong, Sally ^a   Mulder, Lubbertus C F ^a   Wilkinson, David A ^b   Reinhart, Amy L ^c   LaRosa, Gregory ^c   Nibbs, Robert ^d   O'Brien, Thomas R ^e   Michael, Nelson L ^f   Connor, Ruth I ^a   MacDonald, Marcy ^g   Busch, Michael ^h   Koup, Richard A ^b   Landau, Nathaniel R ^a,i  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

^d BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^e NATIONAL CANCER INSTITUTE   (United States)

^f WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h Blood Centers of the Pacific   (United States)

ⁱ SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; DNA; INTERLEUKIN 2; MESSENGER RNA; PHYTOHEMAGGLUTININ; RNA; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS INFECTION;

EID: 0033056003     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.3.2450-2459.1999     Document Type: Article

References (53)

1. Amara, A., S. L. Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M. Baggiolini, J. L. Virelizier, and F. Arenzana-Seisdedos. 1997. HIV coreceptor downregulation as antiviral principle: SDF-lalpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139-146.
2. Balotta, C., P. Bagnarelli, M. Violin, A. L. Ridolfo, D. Zhou, A. Berlusconi, S. Corvasce, M. Corbellino, M. Clementi, M. Clerici, M. Moroni, and M. Galli. 1997. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 11:F67-F71.
3. Benkirane, M., D. Y. Jin, R. F. Chun, R. A. Koup, and K. T. Jeang. 1997. Mechanism of transdominant inhibition of CCR5-mediated HIV-I infection by ccr5delta32. J Biol. Chem. 272:30603-30605.
4. Berkhout. T. A., H. M. Sarau, K. Moores, J. R. White, N. Elshourbagy, E. Appelbaum, R. J. Reape, M. Brawner, J. Makwana, J. J. Foley, D. B. Schmidt, C. lmburgia, D. McNulty, J. Matthews, K. O'Donnell, D. O'Shannessy, M. Scott, P. H. E. Groot, and C. Macphee. 1997. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the rnonocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J. Biol. Chem. 272:16404-16413.
5. Biti, R., R. Ffrench, J. Young, B. Bennetts, G. Stewart, and T. Liang. 1997. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3:252-253.
6. Bleui, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930.
7. Busch, M. P. 1996 Residual risks of viral transmission by transfusions and projected yields of additional screening tests. Retrovirus Epidemiology Donors Study (REDS). Transfus. Clin. Biol. 3:7-11.
8. Carroll, R. G., J. L. Riley, B. L. Levine, Y. Feng, S. Kaushal, D. W. Ritchey, W. Bernstein, O. S. Weislow, C. R. Brown, E. A. Berger, C. H. June, and D. C. St. Louis. 1997. Differential regulation of HIV-I fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science 276:273-276.
9. Connor, R. I, B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mono-nuclear phagocytes. Virology 206:936-944.
10. Dean, M., M. Carrington, C. Winkler, G. A. Hultley, M. W. Smith, R. Allikmets, J, J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, and S. O'Brien. 1996. Genetic restriction of HIV-I infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862.
11. Deng, D., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-I. Nature 381:661-666.
12. Endres, M. J., P. R-Clapham, M. Marsh, M. Ahu-ja, J. D. Turner, A. McKnight, J. F. Thomas, B. Stoebenau-Haggarty, S. Choe, P. J. Vance, T. N. Wells, C. A. Power, S. S. Suttenvala, R. W. Doms, N. R. Landau, and J. A. Hoxie. 1996. CD4-independent infection by HIV-2 is mediated by fusin/ CXCR4. Cell 96:745-756.
13. Eugen-Olsen, J., A. K. Iversen, P. Garred, U. Koppelhus, C. Pedersen, T. L. Benfield, A. M. Sorensen, T. Katzenstein, E. Dickmeiss, J. Gerstoft, P. Skinhoj, A. Svejgaard, J. O. Nielsen, and B. Hofmann. 1997. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 11:305-310.
14. Fauci, A. S. 1996. Host factors and the pathogenesis of HI V-induced disease. Nature 384:529-534.
15. Garcia-Zepeda, E. A., C. Combadiere, M. E. Rothenberg, M. N. Sarafi. F. Lavigne, Q. Hamid, P. M. Murphy, and A. D. Luster. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:5613-5626.
16. Guignard, F., C. Combadiere, H. Lee Tiffany, and P. M. Murphy. 1998. Gene organization and promoter function for CC chemokine receptor 5 (CCR5). J. Immunol. 160:985-992.
17. Hebert, T. E., and M. Bouvier. 1998. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem. Cell Biol. 76:1-11.
18. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. He, S. Rang. D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. R. Landau, J. Phair, D. D. Ho, and R. A. Koup. 1996. Tne role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
19. Huang, Y., L. Zhang, and D. D. Ho. 1995. Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69:8142-8146.
20. Katzenstein, T. L., J. Eugen-Olsen, B. Hofmann, T. Benfield, C. Pedersen, A. K. Iversen, A. M. Sorensen, P. Garred, U. Koppelhus, A. Svejgaard, and J. Gerstoft. 1997. HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HlV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 16:10-14.
21. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228-232.
22. Kostrikis, L. G., Y. Huang, J. P. Moore, S. M. Wolinsky, L. Zhang, Y. Guo, L. Deutsch, J. Phair, N. A. U., and D. D. Ho. 1998. A chemokine receptor CCR2 allele delays HIV-I disease progression and is associated with a CCR5 promoter mutation. Nat. Med. 4:350-353.
23. Krupnick, J. G., and J. L. Benovic. 1998. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38:289-319.
24. Landau, N. R., and D. R. Littman. 1992. A packaging system for producing murine leukemia virus vectors with variable tropism. J. Virol. 66:5110-5113.
25. LaRosa, G. J., A. L. Reinhart, L. L. Yang, and N. Kassam. Unpublished data.
26. Lee, B., B. J. Doranz, S. Rana, Y. Yi, M. Mellado, J. M. R. Frade, A. C. Martinez, S. J. O'Brien, M. Dean, R. G. collman, and R. W. Doms. 1998. Influence of the CCR2-V641 polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J. Virol. 72:7450-7458.
27. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-I coreceptor accounts for resistance of some multiple-exposed individuals to HIV-1 infection. Cell 86:367-377.
28. Liu, R., X. Zhao, T. Gurney, and N. R. Landau. 1998. Functional analysis of transcriptional regulatory elements in the CCR5 promoter. AIDS Res. Hum. Retroviruses 14:1509-1519.
29. Mariani, R. Unpublished data.
30. Mariani, R., F. Kirchhof, T. C. Greenough, J. L. Sullivan, R. C. Desrosiers, and J. Skowronski. 1996. High frequency of defective nef alleles in a longterm survivor with nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 70:7752-7764.
31. Meyer, L., M. Magierowska, J. B. Hubert, C. Rouzioux, C. Deveau, F. Sanson, P. Debre, J. F. Delfraissy, and I. Theodorou. 1997. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS 11:F73-F78.
32. Michael, N. L., G. Chang, L. A. d'Arcy, P. K. Ehrenberg, R. Mariani, M. P. Busch, D. L. Birx, and D. H. Schwartz. 1995. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 69:4228-4236.
33. Michael, N. L., L. G. Louie, A. L. Rohrbaugh, K. A. Schultz, D. E. Dayhoff, C. E. Wang, and H. W. Sheppard. 1997. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat. Med, 3: 1160-1162.
34. Morawetz, R. A., G. P. Rizzardi, D. Glauser, O. Rutschmann, B. Hirsche), L. Perrin, M. Opravil, M, Flepp, J. von Overbeck, M. P. Glauser, S. Ghezzi, E. Vicenzi, G. Poli, A. Lazzarin, and G. Pantaleo. 1997. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCRS/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort. Eur. J. Immunol. 27:3223-3227.
35. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
36. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Cloning and analysis of the promoter region of CCR5. a coreceptor for HIV-1 entry. J. Immunol. 159:5441-5449.
37. Mummidi, S., S. S. Ahuja, E. Gonzalez, S. A. Anderson, E. N. Santiago, K. T. Stephan, F. E. Craig, P. O'Connell, V. Tryon, R. A. Clark, M. J. Dolan, and S. K. Ahuja. 1998. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med. 4:786-793.
38. Mummidi, S., S. S. Ahuja, B. L. McDaniel, and S. K. Ahuja. 1997. The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J. Biol. Chem. 272: 30662-30671.
39. Nibbs, R. J. B., S. M. Wylie, I. B. Pragnell, and G. J. Graham. 1997. Cloning and characterization of a novel murine beta chemokine receptor. D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5. J. Biol. Chem. 272:12495-12504.
40. O'Brien, T. R., C. Winkler, M. Dean, J. A. Nelson, M. Carrington, N. L. Michael, and G. C. N. White. 1997. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349:1219. (Letter.)
41. Paxton, W. A., R. Liu, S. Kang, L. Wu, T. R. Gingeras, N. R. Landau, C. R. Mackay, and R. A. Koup. 1998. Reduced HlV-1 infcctability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of ß-chemokines. Virology 244:66-73.
42. Paxton, W. A., S. R. Martin, D. Tse, T. R. O'Brien, J. Skumick, N. L. VanDevanler, N. Padian, J. F. Braun, D. P. Kotler, S. M. Wolinsky, and R. A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:412-417.
43. Salvi, R., A. R. Garbuglia, A. Di Caro, S. Pulciani, F. Montella, and A. Benedetto. 1998. Grossly defective nef gene sequences in a human immuno-deficiency virus type 1-seropositive long-term nonprogressor. J. Virol. 72: 3646-3657.
44. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-1 infection in Caucasian individuals hearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
45. Schrager, L. K., J. M. Young, M. G. Fowler, B. J. Mathieson, and S. H. Vermund. 1994. Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 8:1123-1128.
46. Smith, M. W., M. Dean, M. Carrington, C. Winkler, G. A. Hutlley, D. A. Lomb, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov. K. Hoots, M. W. Hilgartner, and S. J. O'Brien. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-965.
47. Solari, R., R. E. Offord, S. Remy, J. P. Aubry, T. Wells, E. Whitehorn, T. Oung, and A. E. Proudfoot. 1997. Receptor-mediated endocytosis of CC-chemokines. J. Biol. Chem. 272:9617-9620.
48. Theodorou, I., L. Meyer, M. Magierowska, C. Katlama, C. Rouzioux, and S. S. Group. 1997. HIV-1 infection in an individual homozygous for CCR5delta32. Lancet 349:1210-1220.
49. Valentin, A., W. Lu, M. Rosati, R. Schneider, J. Albert, A. Karlsson, and G. N. Pavlakis. 1998. Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc. Natl. Acad. Sci. USA 95:8886-8891.
50. Winkler, C., W. Modi, M. W. Smith, G. W. Nelson, X. Wu, M. Carrington, M. Dean, T. Honjo, K. Tashiro, D. Y abe, S. Buchbinder, E. Vittinghoff. J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Detels, S. Donneld, A. Willougbby, E. Gomperts, D. Vlahov, J. Phair, and S. J. O'Brien. 1998. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenler AIDS Cohort Study (MACS). Multicenter Hemophilia Cohort Study (MHCS). San Francisco City Cohort. Science 279:389-393.
51. Wu, L, W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro. J. Exp. Med. 185:1681-1691.
52. Zimmerman, P. A, A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Corabadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, M. Vac-carezza, P. E. Kennedy. V. Kumaraswami, J. V. Giorgi, R. Detels, J. Hunter, M. Chopek, E. A. Berger, A. S. Fauci, T. B. Nutman, and P. M. Murphy. 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3:23-36.
53. Zuck, T. F., R. A. Thomson, G. B. Schreiber, R. O. Gilcher, S. H. Kleinman, E. L. Murphy, H. E. Ownby, A. E. Williams, M. P. Busch, J. W. Smith, C. C. Nass, C. G. Hollingsworth, and G. J. Nemo. 1995. The Retrovinjs Epidemiology Donor Study (REDS): rationale and methods. Transfusion 35:944-951.